{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:00Z","timestamp":1790128980980,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Women living with hepatitis C virus (HCV) are rarely addressed in research and may be overrepresented within key populations requiring additional support to access HCV care and treatment.  We constructed the HCV care cascade among people diagnosed with HCV in British Columbia, Canada, as of 2019 to compare progress in care and treatment and to assess sex\/gender gaps in HCV treatment access.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The BC Hepatitis Testers Cohort includes 1.7\u00a0million people who tested for HCV, HIV, reported cases of hepatitis B, and active tuberculosis in BC from 2000 to 2019. Test results were linked to medical visits, hospitalizations, cancers, prescription drugs, and mortality data. Six HCV care cascade stages were identified: (1) antibody diagnosed; (2) RNA tested; (3) RNA positive; (4) genotyped; (5) initiated treatment; and (6) achieved sustained virologic response (SVR). HCV care cascade results were assessed for women, and an \u2018inverse\u2019 cascade was created to assess gaps, including not being RNA tested, genotyped, or treatment initiated, stratified by sex.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 2019, 52,638 people with known sex were anti-HCV positive in BC; 37% (19,522) were women. Confirmatory RNA tests were received by 86% (16,797\/19,522) of anti-HCV positive women and 83% (27,353\/33,116) of men. Among people who had been genotyped, 68% (6756\/10,008) of women and 67% (12,640\/18,828) of men initiated treatment, with 94% (5023\/5364) of women and 92% (9147\/9897) of men achieving SVR. Among the 3252 women and 6188 men not yet treated, higher proportions of women compared to men were born after 1975 (30% vs. 21%), had a mental health diagnosis (42% vs. 34%) and had used injection drugs (50% vs. 45%). Among 1619 women and 2780 men who had used injection drugs and were not yet treated, higher proportions of women than men used stimulants (64% vs. 57%), and opiates (67% vs. 60%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Women and men appear to be equally engaged into the HCV care cascade; however, women with concurrent social and health conditions are being left behind. Treatment access may be improved with approaches that meet the needs of younger women, those with mental health diagnoses, and women who use drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-021-01470-7","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T03:14:37Z","timestamp":1631502877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Margo E.","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia R.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawuena","family":"Binka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Vel\u00e1squez Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahn","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasina","family":"Samji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sauve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neora","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Z.","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"Suppl 3","key":"1470_CR1","doi-asserted-by":"publisher","first-page":"S81-5","DOI":"10.1093\/infdis\/jiu057","volume":"209","author":"R Baden","year":"2014","unstructured":"Baden R, Rockstroh JK, Buti M. Natural history and management of hepatitis C: does sex play a role? J Infect Dis. 2014;209 Suppl 3:S81-5.","journal-title":"J Infect Dis"},{"issue":"4","key":"1470_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MEG.0000000000000567","volume":"28","author":"DJ Corsi","year":"2016","unstructured":"Corsi DJ, Karges W, Thavorn K, Crawley AM, Cooper CL. Influence of female sex on hepatitis C virus infection progression and treatment outcomes. Eur J Gastroenterol Hepatol. 2016;28(4):405\u201311.","journal-title":"European journal of gastroenterology & hepatology"},{"key":"1470_CR3","doi-asserted-by":"crossref","unstructured":"Kushner T, Terrault NA. Hepatitis C in pregnancy: a unique opportunity to improve the hepatitis C cascade of care. Hepatol Commun. 2019;3(1):20\u20138.","DOI":"10.1002\/hep4.1282"},{"issue":"4","key":"1470_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.21111","volume":"43","author":"A Ropponen","year":"2006","unstructured":"Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology. 2006;43(4):723\u20138.","journal-title":"Hepatology"},{"issue":"5","key":"1470_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1478-3231.2010.02218.x","volume":"30","author":"A Safir","year":"2010","unstructured":"Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int Off J Int Assoc Study Liver. 2010;30(5):765\u201370.","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"7","key":"1470_CR6","first-page":"e1-e25","volume":"39","author":"M Boucher","year":"2017","unstructured":"Boucher M, Gruslin A. No. 96-The reproductive care of women living with hepatitis C infection. J Obstet Gynaecol Can. 2017;39(7):e1-e25.","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"1470_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/cid\/ciu447","volume":"59","author":"L Benova","year":"2014","unstructured":"Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59(6):765\u201373.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1470_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/cid\/cix768","volume":"66","author":"A Esmaeili","year":"2018","unstructured":"Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, et al. The effect of female sex on hepatitis C incidence among people who inject drugs: results from the International Multicohort InC3 Collaborative. Clin Infect Dis. 2018;66(1):20\u20138.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"1470_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","volume":"66","author":"SW Patrick","year":"2017","unstructured":"Patrick SW, Bauer AM, Warren MD, Jones TF, Wester C. Hepatitis C virus infection among women giving birth - Tennessee and United States, 2009\u20132014. MMWR Morb Mortal Wkly Rep. 2017;66(18):470\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"1470_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1155\/2015\/381870","volume":"29","author":"ME Socias","year":"2015","unstructured":"Socias ME, Shannon K, Montaner JS, Guillemi S, Dobrer S, Nguyen P, et al. Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: implications for voluntary hepatitis C virus testing, treatment and care. Can J Gastroenterol Hepatol. 2015;29(8):411\u20136.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"12","key":"1470_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/apc.2010.0142","volume":"24","author":"D Swan","year":"2010","unstructured":"Swan D, Long J, Carr O, Flanagan J, Irish H, Keating S, et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS patient care and STDs. 2010;24(12):753\u201362.","journal-title":"AIDS patient care and STDs"},{"issue":"1","key":"1470_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jrh.12256","volume":"34","author":"M Staton","year":"2018","unstructured":"Staton M, Ciciurkaite G, Havens J, Tillson M, Leukefeld C, Webster M, et al. Correlates of injection drug use among rural appalachian women. J Rural Health. 2018;34(1):31\u201341.","journal-title":"J Rural Health"},{"issue":"9","key":"1470_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/M16-2575","volume":"166","author":"O Falade-Nwulia","year":"2017","unstructured":"Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med. 2017;166(9):637\u201348.","journal-title":"Ann Intern Med"},{"key":"1470_CR14","volume-title":"Blueprint to Inform Hepatitis C Elimination Efforts in Canada","author":"The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups","year":"2019","unstructured":"The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups. Blueprint to Inform Hepatitis C Elimination Efforts in Canada. Montreal, QC: CanHepC; 2019."},{"issue":"12","key":"1470_CR15","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/liv.14227","volume":"39","author":"SR Bartlett","year":"2019","unstructured":"Bartlett SR, Yu A, Chapinal N, Rossi C, Butt Z, Wong S, et al. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals. Liver Int Off J Int Assoc Study Liver. 2019;39(12):2261\u201372.","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"7","key":"1470_CR16","doi-asserted-by":"publisher","first-page":"e1-8","DOI":"10.2105\/AJPH.2016.303180a","volume":"106","author":"R Sokol","year":"2016","unstructured":"Sokol R, Fisher E. Peer support for the hardly reached: a systematic review. Am J Public Health. 2016;106(7):e1-8.","journal-title":"Am J Public Health"},{"issue":"4","key":"1470_CR17","doi-asserted-by":"publisher","first-page":"E605-E14","DOI":"10.9778\/cmajo.20160008","volume":"4","author":"AD Marshall","year":"2016","unstructured":"Marshall AD, Saeed S, Barrett L, Cooper CL, Treloar C, Bruneau J, et al. Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ open. 2016;4(4):E605-E14.","journal-title":"CMAJ open"},{"key":"1470_CR18","unstructured":"British Columbia Ministry of Health. BC Pharmacare Newsletter. In: Division MBaPS, editor. 2017."},{"issue":"3","key":"1470_CR19","doi-asserted-by":"publisher","first-page":"e0150176","DOI":"10.1371\/journal.pone.0150176","volume":"11","author":"NZ Janjua","year":"2016","unstructured":"Janjua NZ, Kuo M, Chong M, Yu A, Alvarez M, Cook D, et al. Assessing hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants. PLoS One. 2016;11(3):e0150176.","journal-title":"PLoS One"},{"issue":"5","key":"1470_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jvh.12650","volume":"24","author":"N Islam","year":"2017","unstructured":"Islam N, Krajden M, Gilbert M, Gustafson P, Yu A, Kuo M, et al. Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort. J Viral Hepat. 2017;24(5):421\u20139.","journal-title":"J Viral Hepat"},{"issue":"19","key":"1470_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.14745\/ccdr.v40i19a02","volume":"40","author":"M Trubnikov","year":"2014","unstructured":"Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. Can Commun Dis Rep. 2014;40(19):429\u201336.","journal-title":"Can Commun Dis Rep"},{"issue":"8 Suppl 2","key":"1470_CR22","first-page":"S17-22","volume":"103","author":"R Pampalon","year":"2012","unstructured":"Pampalon R, Hamel D, Gamache P, Philibert MD, Raymond G, Simpson A. An area-based material and social deprivation index for public health in Quebec and Canada. Can J Public Health. 2012;103(8 Suppl 2):S17-22.","journal-title":"Can J Public Health"},{"issue":"10","key":"1470_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.puhe.2011.05.003","volume":"125","author":"F Lakha","year":"2011","unstructured":"Lakha F, Gorman DR, Mateos P. Name analysis to classify populations by ethnicity in public health: validation of Onomap in Scotland. Public Health. 2011;125(10):688\u201396.","journal-title":"Public Health"},{"issue":"4","key":"1470_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/psp.457","volume":"13","author":"P Mateos","year":"2007","unstructured":"Mateos P. A review of name-based ethnicity classification methods and their potential in population studies. Population, Space and Place. 2007;13(4):243\u201363.","journal-title":"Population, Space and Place"},{"issue":"9","key":"1470_CR25","first-page":"e22943","volume":"6","author":"P Mateos","year":"2011","unstructured":"Mateos P, Longley PA, O\u2019Sullivan D. Ethnicity and Population Structure in Personal Naming Networks. 2011;6(9):e22943.","journal-title":"Ethnicity and Population Structure in Personal Naming Networks"},{"issue":"9","key":"1470_CR26","doi-asserted-by":"publisher","first-page":"e016332","DOI":"10.1136\/bmjopen-2017-016332","volume":"7","author":"L Smith","year":"2017","unstructured":"Smith L, Norman P, Kapetanstrataki M, Fleming S, Fraser LK, Parslow RC, et al. Comparison of ethnic group classification using naming analysis and routinely collected data: application to cancer incidence trends in children and young people. BMJ open. 2017;7(9):e016332.","journal-title":"BMJ open"},{"key":"1470_CR27","unstructured":"Currie E, Jefferis H, Lamb J, Reitz C, Westerby J, Pearce ME. Hep C in Focus: Who Are We Missing? Changing the Hep C Cascade of Care for Women [Webinar]. Pacific AIDS Network; 2020."},{"issue":"8","key":"1470_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/jvh.12684","volume":"24","author":"NZ Janjua","year":"2017","unstructured":"Janjua NZ, Islam N, Wong J, Yoshida EM, Ramji A, Samji H, et al. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study. J Viral Hepat. 2017;24(8):624\u201330.","journal-title":"J Viral Hepat"},{"key":"1470_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12879-016-1683-z","volume":"16","author":"NZ Janjua","year":"2016","unstructured":"Janjua NZ, Yu A, Kuo M, Alvarez M, Cook D, Wong J, et al. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort. BMC Infect Dis. 2016;16:334.","journal-title":"BMC Infect Dis"},{"issue":"22","key":"1470_CR30","doi-asserted-by":"publisher","first-page":"E677-E87","DOI":"10.1503\/cmaj.170453","volume":"190","author":"H Shah","year":"2018","unstructured":"Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, et al. The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. Canadian Medical Association Journal. 2018;190(22):E677-E87.","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"1470_CR31","doi-asserted-by":"publisher","first-page":"ofx109","DOI":"10.1093\/ofid\/ofx109","volume":"4","author":"M Castrejon","year":"2017","unstructured":"Castrejon M, Chew KW, Javanbakht M, Humphries R, Saab S, Klausner JD. Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infect Dis. 2017;4(3):ofx109.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"1470_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ajg.2014.11","volume":"109","author":"SF Altekruse","year":"2014","unstructured":"Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109(4):542\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1470_CR33","doi-asserted-by":"publisher","first-page":"e740-6","DOI":"10.1016\/j.ijid.2011.05.018","volume":"15","author":"JW Yu","year":"2011","unstructured":"Yu JW, Sun LJ, Zhao YH, Kang P, Yan BZ. Impact of sex on virologic response rates in genotype 1 chronic hepatitis C patients with peginterferon alpha-2a and ribavirin treatment. Int J Infect Dis. 2011;15(11):e740-6.","journal-title":"Int J Infect Dis"},{"key":"1470_CR34","unstructured":"Pearce M, Yu A, Alvarez M, Bartlett SR, Binka M, Jeong D, et al., editors. Frequency of Prenatal Hepatitis C Screening and Subsequent Diagnoses in British Columbia, 2018. Perinatal Services BC Healthy Mothers and Healthy Babies Conference; 2020 February 21\u201322, 2020; Vancouver, BC."},{"issue":"3","key":"1470_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/cid\/ciw249","volume":"63","author":"F Kanwal","year":"2016","unstructured":"Kanwal F, Kramer J, El-Serag H, Frayne S, Cao Y, Taylor T, et al. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. Clinical Infectious Diseases. 2016;63(3):291\u20139.","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"1470_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/ppe.12481","volume":"32","author":"C Gowda","year":"2018","unstructured":"Gowda C, Kennedy S, Glover C, Prasad MR, Wang L, Honegger JR. Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems. Paediatr Perinat Epidemiol. 2018;32(4):401\u201310.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"28","key":"1470_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.15585\/mmwr.mm6528a2","volume":"65","author":"A Koneru","year":"2016","unstructured":"Koneru A, Nelson N, Hariri S, Canary L, Sanders KJ, Maxwell JF, et al. Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65(28):705\u201310.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"1470_CR38","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s10995-017-2316-x","volume":"21","author":"K Page","year":"2017","unstructured":"Page K, Leeman L, Bishop S, Cano S, Bakhireva LN. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program. Matern Child Health J. 2017;21(9):1778\u201383.","journal-title":"Matern Child Health J"},{"issue":"7","key":"1470_CR39","first-page":"e309-e16","volume":"64","author":"K Gartner","year":"2018","unstructured":"Gartner K, Elliott K, Smith M, Pearson H, Hunt G, Martin RE. \u201cPeople in regular society don\u2019t think you can be a good mother and have a substance use problem\u201d: Participatory action research with women with substance use in pregnancy. Can Fam Physician. 2018;64(7):e309-e16.","journal-title":"Can Fam Physician"},{"key":"1470_CR40","doi-asserted-by":"publisher","first-page":"17433","DOI":"10.7448\/IAS.16.1.17433","volume":"16","author":"AJ Carter","year":"2013","unstructured":"Carter AJ, Bourgeois S, O\u2019Brien N, Abelsohn K, Tharao W, Greene S, et al. Women-specific HIV\/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV\/AIDS. J Int AIDS Soc. 2013;16:17433.","journal-title":"J Int AIDS Soc"},{"key":"1470_CR41","doi-asserted-by":"crossref","unstructured":"Gross MS, Ruth AR, Rasmussen SA. Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy. J Med Ethics. 2020.","DOI":"10.1136\/medethics-2019-105692"},{"issue":"2","key":"1470_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3138\/canlivj.1.2.004","volume":"1","author":"C Greenaway","year":"2018","unstructured":"Greenaway C, Makarenko I, Tanveer F, Janjua N. Addressing hepatitis C in the foreign-born population: A key to hepatitis C virus elimination in Canada. Canadian Liver Journal. 2018;1(2):34\u201350.","journal-title":"Canadian Liver Journal"},{"key":"1470_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2019.08.003","volume":"74","author":"ME Pearce","year":"2019","unstructured":"Pearce ME, Jongbloed K, Demerais L, MacDonald H, Christian WM, Sharma R, et al. \u201cAnother thing to live for\u201d: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. Int J Drug Policy. 2019;74:52\u201361.","journal-title":"Int J Drug Policy"},{"key":"1470_CR44","doi-asserted-by":"crossref","unstructured":"Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. Journal of general internal medicine. 2018.","DOI":"10.1007\/s11606-018-4649-6"},{"key":"1470_CR45","doi-asserted-by":"crossref","unstructured":"Shearer Lambert J, McHugh T, Perry N, Murphy L, Walsh J, Mantoy-Meade P, et al. Development of hepfriend; a dublin community hepatitis c peer support model. International Journal of Integrated Care. 2018;18.","DOI":"10.5334\/ijic.s2368"},{"issue":"39","key":"1470_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.15585\/mmwr.mm6839a1","volume":"68","author":"JY Ko","year":"2019","unstructured":"Ko JY, Haight SC, Schillie SF, Bohm MK, PM. D. National Trends in Hepatitis C Infection by Opioid Use Disorder Status Among Pregnant Women at Delivery Hospitalization - United States, 2000\u20132015. Morbidity and Mortality Weekly Report. 2019;68(39):833\u20138.","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"1470_CR47","doi-asserted-by":"crossref","unstructured":"Bartlett SR, Yu A, Wong S, Pearce ME, Alvarez M, Butt A, et al., editors. Current opioid agonist therapy is associated with hepatitis C virus treatment uptake among people who inject drugs in a population-based data linkage study. Canadian Liver Meeting; 2020 Feb 28-Mar 1; Montreal.","DOI":"10.1016\/S0618-8278(19)30393-7"},{"key":"1470_CR48","unstructured":"Bartlett SR, Yu A, Wong S, Pearce ME, Alvarez M, Butt A, et al., editors. Continued Inequities In The Hepatitis C Cascade Of Care Experienced By People Who Inject Drugs In British Columbia In 2019: A Population-Level Linked Data Study. American Association for the Study of Liver Disease (AASLD); 2020 Nov 13\u201316; ONLINE."},{"key":"1470_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12954-016-0092-3","volume":"13","author":"JS Pedersen","year":"2016","unstructured":"Pedersen JS, Dong H, Small W, Wood E, Nguyen P, Kerr T, et al. Declining trends in the rates of assisted injecting: a prospective cohort study. Harm Reduct J. 2016;13:2.","journal-title":"Harm Reduct J"},{"key":"1470_CR50","doi-asserted-by":"publisher","first-page":"112384","DOI":"10.1016\/j.socscimed.2019.112384","volume":"234","author":"AB Collins","year":"2019","unstructured":"Collins AB, Boyd J, Cooper HLF, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234:112384.","journal-title":"Soc Sci Med"},{"issue":"3","key":"1470_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00126334-200207010-00010","volume":"30","author":"CL Miller","year":"2002","unstructured":"Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O\u2019Shaughnessy MV, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acq Immun Def Synd. 2002;30(3):335\u201341.","journal-title":"J Acq Immun Def Synd"},{"key":"1470_CR52","unstructured":"Statistics Canada. Canadian Community Health Survey - Mental Health (CCHS). 2012. Contract No.: Tables\u00a013-10-0465-01 Mental health indicators."},{"key":"1470_CR53","unstructured":"Statistics Canada. Mental health characteristics: Perceived need for mental health care. 2018. Contract No.: Tables\u00a013-10-0619-01 Mental health characteristics: Perceived need for mental health care."},{"key":"1470_CR54","doi-asserted-by":"crossref","unstructured":"Ho SB, Brau N, Cheung R, Liu L, Sanchez C, Sklar M, et al. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse. Clin Gastroenterol Hepatol. 2015;13(11):2005-14.e1-3.","DOI":"10.1016\/j.cgh.2015.02.022"},{"issue":"2","key":"1470_CR55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.whi.2017.11.007","volume":"28","author":"M Kestler","year":"2018","unstructured":"Kestler M, Murray M, Money D, Sauve L, Pick N. The Oak Tree Clinic: The Envisioned Model of Care for Women Living with Human Immunodeficiency Virus in Canada. Women\u2019s health issues: official publication of the Jacobs Institute of Women\u2019s Health. 2018;28(2):197\u20138.","journal-title":"Women\u2019s health issues: official publication of the Jacobs Institute of Women\u2019s Health"},{"issue":"3","key":"1470_CR56","doi-asserted-by":"publisher","first-page":"E110-E21","DOI":"10.1503\/cmaj.140711","volume":"187","author":"WWL Wong","year":"2015","unstructured":"Wong WWL, Tu HA, Feld JJ, Wong T, Krahn M. Cost-effectiveness of screening for hepatitis C in Canada. CMAJ. 2015;187(3):E110-E21.","journal-title":"CMAJ"},{"key":"1470_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.drugpo.2019.06.003","volume":"72","author":"M Krajden","year":"2019","unstructured":"Krajden M, Cook DA, Wong S, Yu A, Butt ZA, Rossi C, et al. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada. Int J Drug Policy. 2019;72:114\u201322.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1470_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/jvh.13373","volume":"27","author":"A Hamadeh","year":"2020","unstructured":"Hamadeh A, Haines A, Feng Z, Thein HH, Janjua NZ, Krahn M, et al. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies. J Viral Hepat. 2020;27(12):1419\u201329.","journal-title":"J Viral Hepat"},{"key":"1470_CR59","first-page":"189","volume-title":"21 Things You May Not Know About the Indian Act: Helping Canadians Make Reconciliation With Indigenous Peoples a Reality","author":"B Joseph","year":"2018","unstructured":"Joseph B. 21 Things You May Not Know About the Indian Act: Helping Canadians Make Reconciliation With Indigenous Peoples a Reality. Port Coquitlam: Indigenous Relations Press; 2018. 189 p."},{"key":"1470_CR60","unstructured":"British Columbia Centre for Disease Control. BCCDC HCV Stakeholder Survey Highlights. 2020. Available at: https:\/\/hepatitiseducation.med.ubc.ca\/providers\/. Accessed July 24, 2021."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01470-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T08:03:18Z","timestamp":1631520198000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01470-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01470-7","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BC-HTC data are de-identified and analyzed anonymously; thus, informed consent was not required. Institutional ethics approval was provided by the University of British Columbia Research Ethics Board (H14-01649) and all research was carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SRB has received speakers\u2019 honoraria and participated in medical advisory board programs with Gilead Science (all personal payments given as unrestricted donation to BCCDC Foundation). All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}